Immunopathogenesis of Staphylococcus aureus pulmonary infection

Seminars in Immunopathology

Volumn 34, Issue 2, 2012, Pages 281-297

  Parker, Dane ^a   Prince, Alice ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Airway; Epithelial; Lung; Signaling; Staphylococcus aureus; Virulence

Indexed keywords

ALPHA HEMOLYSIN; BACTERIAL PROTEIN; BACTERIAL TOXIN; BETA TOXIN; CLUMPING FACTOR B; INFLAMMASOME; INTERFERON; PANTON VALENTINE LEUKOCIDIN; PHENOL SOLUBLE MODULIN; PROTEIN A; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; COMPLEMENT SYSTEM; DISEASE ASSOCIATION; EXTRACELLULAR SPACE; GENE PRODUCT; HUMAN; IMMUNE EVASION; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INFLUENZA; INTRACELLULAR KILLING; INTRACELLULAR SIGNALING; LUNG INFECTION; METAL METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS INFECTION;

ANIMALS; COINFECTION; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMASOMES; INFLUENZA, HUMAN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, STAPHYLOCOCCAL; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TH17 CELLS; VIRULENCE FACTORS;

EID: 84859858729     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-011-0291-7     Document Type: Review

References (236)

1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S et al (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771 (Pubitemid 47598444)
2. Deleo FR, Otto M, Kreiswirth BN, Chambers HF (2010) Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375:1557-1568
3. Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J et al (2008) Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulso-types USA300 and USA400 in a rat model of pneumonia. J Infect Dis 198:561-570
4. Oswald NC, Shooter RA, Curwen MP (1958) Pneumonia complicating Asian influenza. Br Med J 2:1305-1311
5. Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB et al (2006) Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 12:894-899 (Pubitemid 43848409)
6. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC (2003) Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41:5113-5120 (Pubitemid 37429924)
7. Centers for Disease Control and Prevention (2003) Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 52:88
8. Begier EM, Frenette K, Barrett NL, Mshar P, Petit S, Boxrud DJ et al (2004) A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 39:1446-1453 (Pubitemid 39518207)
9. Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B et al (2005) A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 352:468-475 (Pubitemid 40175973)
10. Gilbert M, MacDonald J, Gregson D, Siushansian J, Zhang K, Elsayed S et al (2006) Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 175:149-154 (Pubitemid 44126248)
11. Centers for Disease Control and Prevention (2003) Methicillin-resistant Staphylococcus aureus infections in correctional facilities- Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 52:992-996
12. Carrillo-Marquez MA, Hulten KG, Hammerman W, Lamberth L, Mason EO, Kaplan SL (2011) Staphylococcus aureus pneumonia in children in the era of community-acquired methicillinresistance at Texas Children's Hospital. Pediatr Infect Dis J 30:545-550
13. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S et al (1998) Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593-598 (Pubitemid 28110205)
14. Boucher HW, Corey GR (2008) Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46(Suppl 5):S344-S349 (Pubitemid 351717321)
15. Finelli L, Fiore A, Dhara R, Brammer L, Shay DK, Kamimoto L et al (2008) Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 122:805-811
16. Garnier F, Tristan A, Francois B, Etienne J, Delage-Corre M, Martin C et al (2006) Pneumonia and new methicillin-resistant Staphylococcus aureus clone. Emerg Infect Dis 12:498-500
17. Risson DC, O'Connor ED, Guard RW, Schooneveldt JM, Nimmo GR (2007) A fatal case of necrotising pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. Med J Aust 186:479-480 (Pubitemid 46806827)
18. Iverson AR, Boyd KL, McAuley JL, Plano LR, Hart ME, McCullers JA (2011) Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis 203:880-888
19. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR et al (2009) Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 106:5883-5888
20. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG et al (2006) Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367:731-739 (Pubitemid 43326291)
21. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau- Remington F (2006) Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 193:1495-1503 (Pubitemid 43794577)
22. Diep BA, Stone GG, Basuino L, Graber CJ, Miller A, des Etages SA et al (2008) The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 197:1523-1530 (Pubitemid 351706482)
23. Montgomery CP, Boyle-Vavra S, Daum RS (2009) The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic background. Infect Immun 77:2650-2656
24. Diep BA, Otto M (2008) The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol 16:361-369
25. Bubeck Wardenburg J, Patel RJ, Schneewind O (2007) Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 75:1040-1044 (Pubitemid 46203470)
26. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O (2007) Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13:1405-1406 (Pubitemid 350224232)
27. Bartlett AH, Foster TJ, Hayashida A, Park PW (2008) Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. J Infect Dis 198:1529-1535
28. Pishchany G, McCoy AL, Torres VJ, Krause JC, Crowe JE Jr, Fabry ME et al (2010) Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe 8:544-550
29. Otto M (2011) A MRSA-terious enemy among us: end of the PVL controversy? Nat Med 17:169-170
30. Kapral FA, Shayegani MG (1959) Intracellular survival of staphylococci. J Exp Med 110:123-138
31. Melly MA, Thomison JB, Rogers DE (1960) Fate of staphylococci within human leukocytes. J Exp Med 112:1121-1130
32. da Silva MC, Zahm JM, Gras D, Bajolet O, Abely M, Hinnrasky J et al (2004) Dynamic interaction between airway epithelial cells and Staphylococcus aureus. Am J Physiol Lung Cell Mol Physiol 287:L543-L551 (Pubitemid 39095910)
33. Belay N, Rasooly A (2002) Staphylococcus aureus growth and enterotoxin A production in an anaerobic environment. J Food Prot 65:199-204 (Pubitemid 34108181)
34. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP (1986) Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet 202:58-61 (Pubitemid 16150393)
35. Novick RP (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48:1429-1449
36. Cheung GY, Wang R, Khan BA, Sturdevant DE, Otto M (2011) Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun 79:1927-1935
37. Traber KE, Lee E, Benson S, Corrigan R, Cantera M, Shopsin B et al (2008) agr function in clinical Staphylococcus aureus isolates. Microbiology 154:2265-2274
38. Heyer G, Saba S, Adamo R, Rush W, Soong G, Cheung A et al (2002) Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung. Infect Immun 70:127-133 (Pubitemid 34028608)
39. Montgomery CP, Boyle-Vavra S, Daum RS (2010) Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One 5:e15177
40. Qazi SN, Counil E, Morrissey J, Rees CE, Cockayne A, Winzer K et al (2001) agr expression precedes escape of internalized Staphylococcus aureus from the host endosome. Infect Immun 69:7074-7082 (Pubitemid 32995468)
41. Shompole S, Henon KT, Liou LE, Dziewanowska K, Bohach GA, Bayles KW (2003) Biphasic intracellular expression of Staphylococcus aureus virulence factors and evidence for Agr-mediated diffusion sensing. Mol Microbiol 49:919-927 (Pubitemid 36981339)
42. Giese B, Glowinski F, Paprotka K, Dittmann S, Steiner T, Sinha B et al (2011) Expression of delta-toxin by Staphylococcus aureus mediates escape from phago-endosomes of human epithelial and endothelial cells in the presence of beta-toxin. Cell Microbiol 13:316-329
43. Jarry TM, Cheung AL (2006) Staphylococcus aureus escapes more efficiently from the phagosome of a cystic fibrosis bronchial epithelial cell line than from its normal counterpart. Infect Immun 74:2568-2577 (Pubitemid 43672964)
44. Bayles KW, Wesson CA, Liou LE, Fox LK, Bohach GA, Trumble WR (1998) Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect Immun 66:336-342 (Pubitemid 28018838)
45. Kubica M, Guzik K, Koziel J, Zarebski M, Richter W, Gajkowska B et al (2008) A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS One 3:e1409
46. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP (2000) Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 164:3713-3722 (Pubitemid 30169827)
47. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, Porcella SF et al (2005) Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 175:3907-3919 (Pubitemid 41292051)
48. Konetschny-Rapp S, Jung G,Meiwes J, Zahner H, Staphyloferrin A (1990) A structurally new siderophore from staphylococci. Eur J Biochem 191:65-74
49. Courcol RJ, Trivier D, Bissinger MC, Martin GR, BrownMR(1997) Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins. Infect Immun 65:1944-1948 (Pubitemid 27193624)
50. Dale SE, Doherty-Kirby A, Lajoie G, Heinrichs DE (2004) Role of siderophore biosynthesis in virulence of Staphylococcus aureus: identification and characterization of genes involved in production of a siderophore. Infect Immun 72:29-37 (Pubitemid 38018157)
51. Torres VJ, Pishchany G, Humayun M, Schneewind O, Skaar EP (2006) Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J Bacteriol 188:8421-8429 (Pubitemid 44894042)
52. Beasley FC, Marolda CL, Cheung J, Buac S, Heinrichs DE (2011) Staphylococcus aureus transporters Hts, Sir, and Sst capture iron liberated from human transferrin by Staphyloferrin A, Staphyloferrin B, and catecholamine stress hormones, respectively, and contribute to virulence. Infect Immun 79:2345-2355
53. Torres VJ, Attia AS, Mason WJ, Hood MI, Corbin BD, Beasley FC et al (2010) Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia. Infect Immun 78:1618-1628
54. Datta R, Huang SS (2008) Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 47:176-181 (Pubitemid 351920617)
55. Lederer SR, Riedelsdorf G, Schiffl H (2007) Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res 12:284-288 (Pubitemid 47207728)
56. Diller R, Sonntag AK, Mellmann A, Grevener K, Senninger N, Kipp F et al (2008) Evidence for cost reduction based on pre-admission MRSA screening in general surgery. Int J Hyg Environ Health 211:205-212 (Pubitemid 351249218)
57. Patti JM, Allen BL, McGavin MJ, Hook M (1994) MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 48:585-617
58. Hienz SA, Schennings T, Heimdahl A, Flock JI (1996) Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis 174:83-88 (Pubitemid 26255558)
59. Rhem MN, Lech EM, Patti JM, McDevitt D, Hook M, Jones DB et al (2000) The collagen-binding adhesin is a virulence factor in Staphylococcus aureus keratitis. Infect Immun 68:3776-3779 (Pubitemid 30340493)
60. de Bentzmann S, Tristan A, Etienne J, Brousse N, Vandenesch F, Lina G (2004) Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J Infect Dis 190:1506-1515 (Pubitemid 39332192)
61. Mongodin E, Bajolet O, Cutrona J, Bonnet N, Dupuit F, Puchelle E et al (2002) Fibronectin-binding proteins of Staphylococcus aureus are involved in adherence to human airway epithelium. Infect Immun 70:620-630 (Pubitemid 34083821)
62. Schaffer AC, Solinga RM, Cocchiaro J, Portoles M, Kiser KB, Risley A et al (2006) Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect Immun 74:2145-2153
63. McElroy MC, Cain DJ, Tyrrell C, Foster TJ, Haslett C (2002) Increased virulence of a fibronectin-binding protein mutant of Staphylococcus aureus in a rat model of pneumonia. Infect Immun 70:3865-3873 (Pubitemid 34666027)
64. Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ (2006) Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Microbiol Lett 258:290-296
65. Palmqvist N, Patti JM, Tarkowski A, Josefsson E (2004) Expression of staphylococcal clumping factor A impedes macrophage phagocytosis. Microbes Infect 6:188-195 (Pubitemid 38293296)
66. Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T (2001) Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 184:1572-1580 (Pubitemid 33139743)
67. Vernachio J, Bayer AS, Le T, Chai YL, Prater B, Schneider A et al (2003) Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob Agents Chemother 47:3400-3406 (Pubitemid 37345696)
68. Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, Francois P et al (1995) Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 63:4738-4743
69. Weems JJ Jr, Steinberg JP, Filler S, Baddley JW, Corey GR, Sampathkumar P et al (2006) Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 50:2751-2755 (Pubitemid 44198697)
70. O'Brien LM, Walsh EJ, Massey RC, Peacock SJ, Foster TJ (2002) Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell Microbiol 4:759-770 (Pubitemid 35378715)
71. Mazmanian SK, Liu G, Ton-That H, Schneewind O (1999) Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 285:760-763
72. Wertheim HF, Walsh E, Choudhurry R, Melles DC, Boelens HA, Miajlovic H et al (2008) Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med 5:e17
73. Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H, Gouaux JE (1996) Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274:1859-1866 (Pubitemid 26424757)
74. Burlak C, Hammer CH, Robinson MA, Whitney AR, McGavin MJ, Kreiswirth BN et al (2007) Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection. Cell Microbiol 9:1172-1190 (Pubitemid 46547137)
75. Yun YS, Min YG, Rhee CS, Jung IH, Koh YY, Jang TY et al (1999) Effects of alpha-toxin of Staphylococcus aureus on the ciliary activity and ultrastructure of human nasal ciliated epithelial cells. Laryngoscope 109:2021-2024
76. Rose F, Dahlem G, Guthmann B, Grimminger F, Maus U, Hanze J et al (2002) Mediator generation and signaling events in alveolar epithelial cells attacked by S. aureus alpha-toxin. Am J Physiol Lung Cell Mol Physiol 282:L207-L214 (Pubitemid 34654672)
77. Wilke GA, Bubeck Wardenburg J (2010) Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin- mediated cellular injury. Proc Natl Acad Sci USA 107:13473-13478
78. Seeger W, Birkemeyer RG, Ermert L, Suttorp N, Bhakdi S, Duncker HR (1990) Staphylococcal alpha-toxin-induced vascular leakage in isolated perfused rabbit lungs. Lab Invest 63:341-349 (Pubitemid 20334765)
79. Phillips JR, Tripp TJ, Regelmann WE, Schlievert PM, Wangensteen OD (2006) Staphylococcal alpha-toxin causes increased tracheal epithelial permeability. Pediatr Pulmonol 41:1146-1152 (Pubitemid 44893867)
80. McElroy MC, Harty HR, Hosford GE, Boylan GM, Pittet JF, Foster TJ (1999) Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect Immun 67:5541-5544 (Pubitemid 29455343)
81. Bantel H, Sinha B, Domschke W, Peters G, Schulze-Osthoff K, Janicke RU (2001) alpha-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol 155:637-648
82. Jonas D, Walev I, Berger T, Liebetrau M, Palmer M, Bhakdi S (1994) Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun 62:1304-1312 (Pubitemid 24110824)
83. Craven RR, Gao X, Allen IC, Gris D, Bubeck Wardenburg J, McElvania-Tekippe E et al (2009) Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One 4:e7446
84. Munoz-Planillo R, Franchi L, Miller LS, Nunez G (2009) A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol 183:3942-3948
85. Grimminger F, Rose F, Sibelius U, Meinhardt M, Potzsch B, Spriestersbach R et al (1997) Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal alpha-toxin. J Immunol 159:1909-1916 (Pubitemid 127484180)
86. Liang X, Ji Y (2007) Involvement of alpha5beta1-integrin and TNF-alpha in Staphylococcus aureus alpha-toxin-induced death of epithelial cells. Cell Microbiol 9:1809-1821 (Pubitemid 46958805)
87. Bubeck Wardenburg J, Schneewind O (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205:287- 294
88. Ragle BE, Bubeck Wardenburg J (2009) Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect Immun 77:2712-2718
89. Ragle BE, Karginov VA, Bubeck Wardenburg J (2010) Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative. Antimicrob Agents Chemother 54:298-304
90. Aarestrup FM, Larsen HD, Eriksen NH, Elsberg CS, Jensen NE (1999) Frequency of alpha- and beta-haemolysin in Staphylococcus aureus of bovine and human origin. A comparison between pheno- and genotype and variation in phenotypic expression. APMIS 107:425-430
91. Doery HM, Magnusson BJ, Cheyne IM, Sulasekharam J (1963) A phospholipase in staphylococcal toxin which hydrolyses sphingomyelin. Nature 198:1091-1092
92. Marshall MJ, Bohach GA, Boehm DF (2000) Characterization of Staphylococcus aureus beta-toxin induced leukotoxicity. J Nat Toxins 9:125-138 (Pubitemid 30343560)
93. Walev I, Weller U, Strauch S, Foster T, Bhakdi S (1996) Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus. Infect Immun 64:2974-2979 (Pubitemid 26256135)
94. Huseby M, Shi K, Brown CK, Digre J, Mengistu F, Seo KS et al (2007) Structure and biological activities of beta toxin from Staphylococcus aureus. J Bacteriol 189:8719-8726 (Pubitemid 350210043)
95. Kim CS, Jeon SY, Min YG, Rhyoo C, Kim JW, Yun JB et al (2000) Effects of beta-toxin of Staphylococcus aureus on ciliary activity of nasal epithelial cells. Laryngoscope 110:2085-2088
96. Hayashida A, Bartlett AH, Foster TJ, Park PW (2009) Staphylococcus aureus beta-toxin induces lung injury through syndecan-1. Am J Pathol 174:509-518
97. Mehlin C, Headley CM, Klebanoff SJ (1999) An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J Exp Med 189:907-918
98. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M et al (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13:1510-1514 (Pubitemid 350224240)
99. Kretschmer D, Gleske AK, Rautenberg M, Wang R, Koberle M, Bohn E et al (2010) Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 7:463-473
100. Queck SY, Khan BA, Wang R, Bach TH, Kretschmer D, Chen L et al (2009) Mobile genetic element-encoded cytolysin connects virulence to methicillin resistance in MRSA. PLoS Pathog 5:e1000533
101. Joo HS, Cheung GY, Otto M (2011) Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives. J Biol Chem 286:8933-8940
102. Wang R, Khan BA, Cheung GY, Bach TH, Jameson-Lee M, Kong KF et al (2011) Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J Clin Invest 121:238-248
103. Janzon L, Lofdahl S, Arvidson S (1989) Identification and nucleotide sequence of the delta-lysin gene, hld, adjacent to the accessory gene regulator (agr) of Staphylococcus aureus. Mol Gen Genet 219:480-485 (Pubitemid 20009304)
104. Kreger AS, Kim KS, Zaboretzky F, Bernheimer AW (1971) Purification and properties of staphylococcal delta hemolysin. Infect Immun 3:449-465
105. Prevost G, Cribier B, Couppie P, Petiau P, Supersac G, Finck- Barbancon V et al (1995) Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun 63:4121-4129
106. Gladstone GP, Van Heyningen WE (1957) Staphylococcal leucocidins. Br J Exp Pathol 38:123-137
107. Gauduchon V, Werner S, Prevost G, Monteil H, Colin DA (2001) Flow cytometric determination of Panton-Valentine leucocidin S component binding. Infect Immun 69:2390-2395 (Pubitemid 32239708)
108. Miles G, Movileanu L, Bayley H (2002) Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore. Protein Sci 11:894-902 (Pubitemid 34241297)
109. Finck-Barbancon V, Duportail G, Meunier O, Colin DA (1993) Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim Biophys Acta 1182:275-282 (Pubitemid 23310053)
110. Li M, Cheung GY, Hu J, Wang D, Joo HS, Deleo FR et al (2010) Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains. J Infect Dis 202:1866-1876
111. Loffler B, Hussain M, Grundmeier M, Bruck M, Holzinger D, Varga G et al (2010) Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6:e1000715
112. Diep BA, Chan L, Tattevin P, Kajikawa O, Martin TR, Basuino L et al (2010) Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 107:5587-5592
113. Genestier AL, Michallet MC, Prevost G, Bellot G, Chalabreysse L, Peyrol S et al (2005) Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 115:3117-3127 (Pubitemid 41567576)
114. Zivkovic A, Sharif O, Stich K, Doninger B, Biaggio M, Colinge J et al (2011) TLR 2 and CD14 mediate innate immunity and lung inflammation to staphylococcal Panton-Valentine leukocidin in vivo. J Immunol 186:1608-1617
115. Ward PD, Turner WH (1980) Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin. Infect Immun 28:393-397 (Pubitemid 10102072)
116. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V et al (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128-1132 (Pubitemid 30265628)
117. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T et al (2005) Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40:100-107 (Pubitemid 40053465)
118. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753-759 (Pubitemid 34215075)
119. Vardakas KZ, Matthaiou DK, Falagas ME (2009) Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia. Eur Respir J 34:1148-1158
120. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, Benito Y et al (2007) Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315:1130-1133 (Pubitemid 46328024)
121. Brown EL, Dumitrescu O, Thomas D, Badiou C, Koers EM, Choudhury P et al (2009) The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15:156-164
122. Vandenesch F, Couzon F, Boisset S, Benito Y, Brown EL, Lina G et al (2010) The Panton-Valentine leukocidin is a virulence factor in a murine model of necrotizing pneumonia. J Infect Dis 201:967-969, author reply 969-970
123. Villaruz AE, Bubeck Wardenburg J, Khan BA, Whitney AR, Sturdevant DE, Gardner DJ et al (2009) A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation. J Infect Dis 200:724-734
124. Mollick JA, McMasters RL, Grossman D, Rich RR (1993) Localization of a site on bacterial superantigens that determines T cell receptor beta chain specificity. J Exp Med 177:283-293 (Pubitemid 23117078)
125. Li H, Llera A, Malchiodi EL, Mariuzza RA (1999) The structural basis of T cell activation by superantigens. Annu Rev Immunol 17:435-466 (Pubitemid 29241131)
126. Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248:705-711
127. Lambris JD, Ricklin D, Geisbrecht BV (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6:132-142
128. Bekeredjian-Ding I, Inamura S, Giese T, Moll H, Endres S, Sing A et al (2007) Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J Immunol 178:2803-2812 (Pubitemid 46333158)
129. Silverman GJ, Nayak JV, Warnatz K, Hajjar FF, Cary S, Tighe H et al (1998) The dual phases of the response to neonatal exposure to a VH family-restricted staphylococcal B cell superantigen. J Immunol 161:5720-5732 (Pubitemid 28519141)
130. Smith EJ, Visai L, Kerrigan SW, Speziale P, Foster TJ (2011) The Sbi protein: a multifunctional immune evasion factor of Staphylococcus aureus. Infect Immun 79:3801-3809
131. Moks T, Abrahmsen L, Nilsson B, Hellman U, Sjoquist J, Uhlen M (1986) Staphylococcal protein A consists of five IgG-binding domains. Eur J Biochem 156:637-643
132. Uhlen M, Guss B, Nilsson B, Gatenbeck S, Philipson L, Lindberg M (1984) Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem 259:1695-1702 (Pubitemid 14146555)
133. Rajagopalan G, Sen MM, Singh M, Murali NS, Nath KA, Iijima K et al (2006) Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response. Shock 25:647-656 (Pubitemid 44297027)
134. Zen K, Masuda J, Ogata J (1996) Monocyte-derived macrophages prime peripheral T cells to undergo apoptosis by cell-cell contact via ICAM-1/LFA-1-dependent mechanism. Immunobiology 195:323-333 (Pubitemid 26275777)
135. Miller EJ, Nagao S, Carr FK, Noble JM, Cohen AB (1996) Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA). Inflamm Res 45:386-392 (Pubitemid 26280562)
136. Fuller AF Jr, Swartz MN, Wolfson JS, Salzman R (1980) Toxic-shock syndrome. N Engl J Med 303:881
137. Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT et al (1980) Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303:1436-1442
138. Osterholm MT, Davis JP, Gibson RW, Forfang JC, Stolz SJ, Vergeront JM (1982) Toxic shock syndrome: relation to catamenial products, personal health and hygiene, and sexual practices. Ann Intern Med 96:954-958 (Pubitemid 12088909)
139. Reingold AL, Dan BB, Shands KN, Broome CV (1982) Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet 1:1-4 (Pubitemid 12246558)
140. Wilkins EG, Nye F, Roberts C, de Saxe M (1985) Probable toxic shock syndrome with primary staphylococcal pneumonia. J Infect 11:231-232 (Pubitemid 16212101)
141. MacDonald KL, Osterholm MT, Hedberg CW, Schrock CG, Peterson GF, Jentzen JM et al (1987) Toxic shock syndrome. A newly recognized complication of influenza and influenza-like illness. JAMA 257:1053-1058
142. Hirsch B, Stair T, Horowitz BZ, Brooks C (1984) Toxic shock syndrome from staphylococcal pharyngitis. Ear Nose Throat J 63:494-497 (Pubitemid 14016345)
143. Dann EJ, Weinberger M, Gillis S, Parsonnet J, Shapiro M, Moses AE (1994) Bacterial laryngotracheitis associated with toxic shock syndrome in an adult. Clin Infect Dis 18:437-439 (Pubitemid 24086319)
144. Zhang WJ, Sarawar S, Nguyen P, Daly K, Rehg JE, Doherty PC et al (1996) Lethal synergism between influenza infection and staphylococcal enterotoxin B in mice. J Immunol 157:5049-5060 (Pubitemid 126449586)
145. Dinges MM, Orwin PM, Schlievert PM (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13:16-34 (table of contents) (Pubitemid 30039341)
146. Martin WJ, Marcus S (1964) Relation of pyrogenic and emetic properties of enterobacteriaceal endotoxin and of staphylococcal enterotoxin. J Bacteriol 87:1019-1026
147. Bachert C, Gevaert P, van Cauwenberge P (2002) Staphylococcus aureus enterotoxins: a key in airway disease? Allergy 57:480-487 (Pubitemid 34539120)
148. Mariano NS, de Mello GC, Ferreira T, Schenka A, Camargo EA, de Nucci G et al (2010) Pre-exposure to staphylococcal enterotoxin A exacerbates the pulmonary allergic eosinophil recruitment in rats. Int Immunopharmacol 10:43-49
149. Bachert C, Gevaert P, Howarth P, Holtappels G, van Cauwenberge P, Johansson SG (2003) IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J Allergy Clin Immunol 111:1131-1132 (Pubitemid 36570878)
150. Rossi RE, Monasterolo G (2004) Prevalence of serum IgE antibodies to the Staphylococcus aureus enterotoxins (SAE, SEB, SEC, SED, TSST-1) in patients with persistent allergic rhinitis. Int Arch Allergy Immunol 133:261-266 (Pubitemid 38529219)
151. O'Brien GJ, Riddell G, Elborn JS, Ennis M, Skibinski G (2006) Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells. Respir Res 7:115
152. Patou J, Gevaert P, Van Zele T, Holtappels G, van Cauwenberge P, Bachert C (2008) Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 121:110-115
153. Herz U, Ruckert R, Wollenhaupt K, Tschernig T, Neuhaus-Steinmetz U, Pabst R et al (1999) Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness-amodel for non-allergic asthma. Eur J Immunol 29:1021-1031 (Pubitemid 29119083)
154. Desouza IA, Franco-Penteado CF, Camargo EA, Lima CS, Teixeira SA, Muscara MN et al (2006) Acute pulmonary inflammation induced by exposure of the airways to staphylococcal enterotoxin type B in rats. Toxicol Appl Pharmacol 217:107-113 (Pubitemid 44635656)
155. Rajagopalan G, Iijima K, Singh M, Kita H, Patel R, David CS (2006) Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun 74:1284-1296 (Pubitemid 43185568)
156. Shinbori T, Matsuki M, Suga M, Kakimoto K, Ando M (1996) Induction of interstitial pneumonia in autoimmune mice by intratracheal administration of superantigen staphylococcal enterotoxin B. Cell Immunol 174:129-137 (Pubitemid 26426205)
157. Hellings PW, Hens G, Meyts I, Bullens D, Vanoirbeek J, Gevaert P et al (2006) Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B. Clin Exp Allergy 36:1063-1071 (Pubitemid 44166624)
158. Yu RL, Dong Z (2009) Proinflammatory impact of Staphylococcus aureus enterotoxin B on human nasal epithelial cells and inhibition by dexamethasone. Am J Rhinol Allergy 23:15-20
159. Nguyen T, Ghebrehiwet B, Peerschke EI (2000) Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. Infect Immun 68:2061-2068 (Pubitemid 30164837)
160. Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S et al (2008) S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation. Mol Immunol 45:1600-1611 (Pubitemid 351227405)
161. Burman JD, Leung E, Atkins KL, O'Seaghdha MN, Lango L, Bernado P et al (2008) Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. J Biol Chem 283:17579-17593
162. Rooijakkers SH, van Wamel WJ, Ruyken M, van Kessel KP, van Strijp JA (2005) Anti-opsonic properties of staphylokinase. Microbes Infect 7:476-484 (Pubitemid 40603446)
163. Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A (2004) Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 172:1169-1176 (Pubitemid 38113778)
164. Verkaik NJ, Benard M, Boelens HA, de Vogel CP, Nouwen JL, Verbrugh HA et al (2011) Immune evasion cluster-positive bacteriophages are highly prevalent among human Staphylococcus aureus strains, but they are not essential in the first stages of nasal colonization. Clin Microbiol Infect 17:343-348
165. Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB et al (2005) Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nat Immunol 6:920-927 (Pubitemid 43090447)
166. Postma B, Poppelier MJ, van Galen JC, Prossnitz ER, van Strijp JA, de Haas CJ et al (2004) Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J Immunol 172:6994-7001 (Pubitemid 38669140)
167. de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC et al (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 199:687-695 (Pubitemid 38316435)
168. Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA et al (2007) Staphylococcal complement evasion by various convertase-blocking molecules. J Exp Med 204:2461-2471 (Pubitemid 47529330)
169. Movitz J (1976) Formation of extracellular protein A by Staphylococcus aureus. Eur J Biochem 68:291-299
170. Schneewind O, Model P, Fischetti VA (1992) Sorting of protein A to the staphylococcal cell wall. Cell 70:267-281
171. Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE et al (1999) Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 37:3556-3563 (Pubitemid 29491091)
172. Koreen L, Ramaswamy SV, Graviss EA, Naidich S, Musser JM, Kreiswirth BN (2004) spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol 42:792-799 (Pubitemid 38222664)
173. Martin FJ, Gomez MI, Wetzel DM, Memmi G, O'Seaghdha M, Soong G et al (2009) Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest 119:1931-1939
174. Kahl BC, Mellmann A, Deiwick S, Peters G, Harmsen D (2005) Variation of the polymorphic region X of the protein A gene during persistent airway infection of cystic fibrosis patients reflects two independent mechanisms of genetic change in Staphylococcus aureus. J Clin Microbiol 43:502-505 (Pubitemid 40096357)
175. Hakoda M, Hayashimoto S, Yamanaka H, Terai C, Kamatani N, Kashiwazaki S (1994) Molecular basis for the interaction between human IgM and staphylococcal protein A. Clin Immunol Immunopathol 72:394-401 (Pubitemid 24275220)
176. Kim HK, Cheng AG, Kim HY, Missiakas DM, Schneewind O (2010) Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med 207:1863-1870
177. Gomez MI, Lee A, Reddy B, Muir A, Soong G, Pitt A et al (2004) Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med 10:842-848 (Pubitemid 39070858)
178. Palmqvist N, Foster T, Tarkowski A, Josefsson E (2002) Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death. Microb Pathog 33:239-249 (Pubitemid 36027032)
179. MacEwan DJ (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 14:477-492
180. Gomez MI, Seaghdha MO, Prince AS (2007) Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling. EMBO J 26:701-709
181. Gomez MI, O'Seaghdha M, Magargee M, Foster TJ, Prince AS (2006) Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J Biol Chem 281:20190-20196
182. Skerrett SJ, Liggitt HD, Hajjar AM, Wilson CB (2004) Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol 172:3377-3381 (Pubitemid 38337914)
183. Shaykhiev R, Behr J, Bals R (2008) Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PLoS One 3:e1393
184. Basbaum C, Li D, Gensch E, Gallup M, Lemjabbar H (2002) Mechanisms by which Gram-positive bacteria and tobacco smoke stimulate mucin induction through the epidermal growth factor receptor (EGFR). Novartis Found Symp 248:171-176, discussion 176-180, 277-182
185. Miller LS, Cho JS (2011) Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 11:505-518
186. Muir A, Soong G, Sokol S, Reddy B, Gomez MI, Van Heeckeren A et al (2004) Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 30:777-783 (Pubitemid 38736900)
187. Mayer AK, Muehmer M, Mages J, Gueinzius K, Hess C, Heeg K et al (2007) Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells. J Immunol 178:3134-3142 (Pubitemid 46333195)
188. Greene CM, Carroll TP, Smith SG, Taggart CC, Devaney J, Griffin S et al (2005) TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J Immunol 174:1638-1646
189. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP (2004) Activation of airway epithelial cells by Toll-like receptor agonists. Am J Respir Cell Mol Biol 31:358-364 (Pubitemid 39180307)
190. Xing Z, Harper R, Anunciacion J, Yang Z, Gao W, Qu B et al (2011) Host immune and apoptotic responses to avian influenza virus H9N2 in human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol 44:24-33
191. von Aulock S, Morath S, Hareng L, Knapp S, van Kessel KP, van Strijp JA et al (2003) Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment. Immunobiology 208:413-422 (Pubitemid 38081364)
192. Hoogerwerf JJ, de Vos AF, Bresser P, van der Zee JS, Pater JM, de Boer A et al (2008) Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. Am J Respir Crit Care Med 178:34-41 (Pubitemid 351919191)
193. Quinn GA, Cole AM (2007) Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology 122:80-89 (Pubitemid 47222598)
194. Takeuchi O, Hoshino K, Akira S (2000) Cutting edge: TLR2- deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165:5392-5396
195. Mullaly SC, Kubes P (2006) The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands. J Immunol 177:8154-8163 (Pubitemid 44846335)
196. Bubeck Wardenburg J, Williams WA, Missiakas D (2006) Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc Natl Acad Sci USA 103:13831-13836 (Pubitemid 44413993)
197. Saba S, Soong G, Greenberg S, Prince A (2002) Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways. Am J Respir Cell Mol Biol 27:561-567 (Pubitemid 35301810)
198. Sorrentino R, de Souza PM, Sriskandan S, Duffin C, Paul-Clark MJ, Mitchell JA (2008) Pattern recognition receptors and interleukin-8 mediate effects of Gram-positive and Gram-negative bacteria on lung epithelial cell function. Br J Pharmacol 154:864-871 (Pubitemid 351821589)
199. 2+-dependent mitogen-activated protein kinase signaling pathways in airway epithelial cells. J Biol Chem 276:19267-19275
200. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM et al (1994) Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921 (Pubitemid 24245635)
201. Der SD, Zhou A, Williams BR, Silverman RH (1998) Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95:15623-15628 (Pubitemid 29018750)
202. Parker D, Martin FJ, Soong G, Harfenist BS, Aguilar JL, Ratner AJ et al (2011) Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio 2:e00016-11
203. Parker D, Cohen TS, Alhede M, Harfenist BS, Martin FJ, Prince A (2011) Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol Jul 21. [Epub ahead of print]
204. Decker T, Muller M, Stockinger S (2005) The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 5:675-687 (Pubitemid 43086170)
205. Charrel-Dennis M, Latz E, Halmen KA, Trieu-Cuot P, Fitzgerald KA, Kasper DL et al (2008) TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe 4:543-554 (Pubitemid 352762959)
206. Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S et al (2002) TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol 3:392-398 (Pubitemid 34308628)
207. Mancuso G, Gambuzza M, Midiri A, Biondo C, Papasergi S, Akira S et al (2009) Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol 10:587-594
208. Chiu YH, Macmillan JB, Chen ZJ (2009) RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138:576-591
209. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K et al (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548
210. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T et al (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777 (Pubitemid 44739521)
211. Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, Pitha PM et al (2005) The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling. J Biol Chem 280:17005-17012 (Pubitemid 41389162)
212. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT et al (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491-496 (Pubitemid 36592443)
213. Schindler C, Plumlee C (2008) Inteferons pen the JAK-STAT pathway. Semin Cell Dev Biol 19:311-318
214. David M, Petricoin E 3rd, Benjamin C, Pine R, Weber MJ, Larner AC (1995) Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 269:1721-1723
215. Lenardo MJ, Fan CM, Maniatis T, Baltimore D (1989) The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57:287-294 (Pubitemid 19112367)
216. Manicone AM, Burkhart KM, Lu B, Clark JG (2008) CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung. Exp Lung Res 34:391-407
217. Qian C, An H, Yu Y, Liu S, Cao X (2007) TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation. Blood 109:3308-3315 (Pubitemid 46572518)
218. + T cells depend on tissue origin and microbial stimulus. J Immunol 176:557-566
219. Martin FJ, Parker D, Harfenist BS, Soong G, Prince A (2011) Participation of CD11c(+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung. Infect Immun 79:1898-1904
220. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K (2005) Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 32:311-318 (Pubitemid 40478306)
221. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417-426 (Pubitemid 35007355)
222. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213-218 (Pubitemid 38902430)
223. Bergsbaken T, Fink SL, Cookson BT (2009) Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7:99-109
224. Mariathasan S, Weiss DS, Newton K, McBride J, O?Rourke K, Roose-Girma M et al (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228-232 (Pubitemid 43372102)
225. Bhakdi S, Muhly M, Korom S, Hugo F (1989) Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect Immun 57:3512-3519 (Pubitemid 19259885)
226. Shimada T, Park BG, Wolf AJ, Brikos C, Goodridge HS, Becker CA et al (2010) Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe 7:38-49
227. Chien YW, Klugman KP, Morens DM (2009) Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med 361:2582-2583
228. Morens DM, Taubenberger JK, Fauci AS (2008) Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198:962-970
229. Lee MH, Arrecubieta C, Martin FJ, Prince A, Borczuk AC, Lowy FD (2010) A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis 201:508-515
230. Small CL, Shaler CR, McCormick S, Jeyanathan M, Damjanovic D, Brown EG et al (2010) Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol 184:2048-2056
231. Kudva A, Scheller EV, Robinson KM, Crowe CR, Choi SM, Slight SR et al (2011) Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol 186:1666-1674
232. Minegishi Y, Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S et al (2009) Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 206:1291-1301
233. Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas J (2011) A modulatory interleukin- 10 response to staphylococcal peptidoglycan prevents Th1/ Th17 adaptive immunity to Staphylococcus aureus. J Infect Dis 204:253-262
234. Niebuhr M, Gathmann M, Scharonow H, Mamerow D, Mommert S, Balaji H et al (2011) Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. Infect Immun 79:1615-1622
235. Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y et al (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30:108-119
236. Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B et al (2008) Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 205:1551-1557 (Pubitemid 351962018)